Recent studies have shown that GPR30 exerts its effects through the activation of the epidermal growth factor receptor (EGFR) transduction pathway in endometrial cancer, breast cancer, and thyroid cancer cells [19,20,27-29]. The gene discussed is EGFR; the disease is thyroid cancer.